CG Oncology, Inc. (CGON) Financial Statements

303 Followers

CG Oncology, Inc. Financial Overview

CG Oncology, Inc.'s market cap is currently $5.72B. The company's EPS TTM is $-2.08; its P/E ratio is -19.42; CG Oncology, Inc. is scheduled to report earnings on February 27, 2026, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 4.04M	$ 1.14M	$ 204.00K	$ 191.00K	$ 10.36M
Gross Profit	$ -607.00K	$ 1.14M	$ 204.00K	$ 176.00K	$ 10.35M
Operating Income	$ -190.77M	$ -114.67M	$ -55.45M	$ -35.25M	$ -12.61M
EBITDA	$ -159.55M	$ -114.63M	$ -55.43M	$ -35.23M	$ -12.38M
Net Income	$ -161.00M	$ -88.04M	$ -48.61M	$ -35.44M	$ -12.84M
Balance Sheet
Cash & Short-Term Investments	$ 742.15M	$ 742.00M	$ 187.67M	$ 143.48M	$ 53.61M
Total Assets	$ 791.59M	$ 754.80M	$ 199.30M	$ 147.75M	$ 58.69M
Total Debt	$ 7.02M	$ 238.00K	$ 1.03M	$ 15.94M	$ 15.13M
Net Debt	$ -25.47M	$ -256.83M	$ -7.24M	$ -72.20M	$ -38.48M
Total Liabilities	$ 38.99M	$ 21.42M	$ 14.51M	$ 22.57M	$ 18.44M
Stockholders' Equity	$ 752.60M	$ 733.38M	$ 184.79M	$ 125.18M	$ 40.25M
Cash Flow
Free Cash Flow	$ -132.48M	$ -78.95M	$ -45.68M	$ -29.82M	$ -13.75M
Operating Cash Flow	$ -132.35M	$ -78.71M	$ -45.68M	$ -29.80M	$ -13.65M
Investing Cash Flow	$ -245.82M	$ -300.76M	$ -121.19M	$ -55.35M	$ -97.00K
Financing Cash Flow	$ 153.59M	$ 628.28M	$ 87.00M	$ 119.69M	$ 15.45M

Currency in USD

CG Oncology, Inc. Earnings and Revenue History

Income Statement >

CG Oncology, Inc. Debt to Assets

Balance Sheet >

CG Oncology, Inc. Cash Flow

Cash Flow >

CG Oncology, Inc. Forecast EPS vs Actual EPS

Earnings >